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Penicillin acylase catalyses the condensation of Ca-
substituted phenylacetic acids with b-lactam nucleophiles,
producing semi-synthetic b-lactam antibiotics. For efficient
synthesis a low affinity for phenylacetic acid and a high
affinity for Ca-substituted phenylacetic acid derivatives is
desirable. We made three active site mutants, aF146Y,
bF24A and aF146Y/bF24A, which all had a 2- to 10-fold
higher affinity for Ca-substituted compounds than wild-
type enzyme. In addition, bF24A had a 20-fold reduced
affinity for phenylacetic acid. The molecular basis of the
improved properties was investigated by X-ray crystallo-
graphy. These studies showed that the higher affinity of
aF146Y for (R)-a-methylphenylacetic acid can be explained
by van der Waals interactions between aY146:OH and
the Ca-substituent. The bF24A mutation causes an
opening of the phenylacetic acid binding site. Only
(R)-a-methylphenylacetic acid, but not phenylacetic acid,
induces a conformation with the ligand tightly bound,
explaining the weak binding of phenylacetic acid. A
comparison of the bF24A structure with other open
conformations of penicillin acylase showed that bF24 has
a fixed position, whereas aF146 acts as a flexible lid on
the binding site and reorients its position to achieve optimal
substrate binding.
Keywords: 3D structure/kinetics/ligand binding/mutants/
penicillin acylase
Introduction
Penicillin acylase (PA) from Escherichia coli ATCC 11105
is a heterodimeric periplasmic protein consisting of a small
a-subunit of 23 kDa and a large b-subunit of 62 kDa. The
enzyme catalyses the hydrolysis of penicillin G to yield
phenylacetic acid (PAA) and 6-aminopenicillanic acid, a build-
ing block of semi-synthetic b-lactam antibiotics (Bruggink
et al., 1998). PA is of biotechnological interest because it
catalyses the condensation of 6-aminopenicillanic acid and a
synthetically produced acyl donor, to produce semi-synthetic
b-lactam antibiotics (Arroyo et al., 2003). The proposed
catalytic cycle starts with a nucleophilic attack by the hydroxyl
group of the active-site serine, bS1, on the carbonyl carbon
atom of the amide or ester bond of the substrate (the amino acid
residues are labelled to indicate the polypeptide chain, a or b,
and the residue number in this chain) (Duggleby et al., 1995).
Via a tetrahedral oxyanion intermediate an acyl-enzyme is
formed concomitant with the departure of the leaving
group. The acyl-enzyme can subsequently be deacylated by
a b-lactam nucleophile yielding a semi-synthetic b-lactam
antibiotic, or by H2O, resulting in the hydrolysis product.
The synthetic acyl donors that are used in the synthesis of
semi-synthetic b-lactam antibiotics are in general activated
PAA derivatives that carry substituents on the Ca position
or on the phenyl ring. For instance, for the synthesis of ampi-
cillin and amoxicillin, amides or esters of a-aminophenylacetic
acid (phenylglycine) and p-hydroxy-a-aminophenylacetic acid
(p-hydroxyphenylglycine) are used, respectively. The produc-
tion of cefamandole requires the use of activated a-hydroxy-
phenylacetic acid (mandelic acid). Unfortunately, the Km
values of PA for the conversion of these derivatives are in
the order of 10–100 mM, which is 100- to 1000-fold higher
than the Km values for substrates with phenylacetic acid as the
acyl group (Margolin et al., 1980; Svedas et al., 1996; Alkema
et al., 1999; Lummer et al., 1999). A higher affinity of PA for
synthetic acyl donors would therefore be desirable for main-
taining a high activity at low substrate concentrations. A sec-
ond requirement for high enzyme activity is a low affinity for
PAA, which is a strong inhibitor of penicillin acylase and may
be present in preparations of 6-aminopenicillanic acid derived
from penicillin G.
The 3D structure of the enzyme with bound PAA revealed
that the acyl binding site is a hydrophobic pocket formed by
the side chains of aM142, aF146, bF24, bV56 and bI177
(Duggleby et al., 1995). One oxygen atom of the carboxylate
group of PAA interacts with the oxyanion-hole residues bN241
and bA69. Binding of para- and meta-substituted phenylacetic
acid derivatives causes the enzyme to switch from a closed to
an open active site conformation (Done et al., 1998; Alkema
et al., 2000; McVey et al., 2001). In the open conformation,
aR145 and aF146 have moved away from the active site,
creating more space in the acyl binding site. Kinetic studies
with Ca-substituted phenylacetic acid derivatives have shown
that the substrate binding site can accommodate small hydro-
phobic substituents, but that large and polar substituents bind
only with low affinity (Svedas et al., 1996). However, no
structural information is available on the binding of these
compounds.
To identify the factors that play a role in the binding of
synthetic acyl donors, we carried out kinetic and crystallo-
graphic studies of wild-type enzyme and the active-site
mutants bF24A and aF146Y, which were found to have an
increased affinity for PAA derivatives with an NH2 group at the
Ca position. The results show that the kinetic properties of the
bF24A mutant can be explained by the enzyme adopting two
distinct stabilizing conformations upon binding of PAA and
(R)-a-methylphenylacetic acid. The aF146Y mutation intro-
duces van der Waals interactions that stabilize the binding of
(R)-a-methylphenylacetic acid.
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Materials and methods
Crystallization of wild-type and mutant penicillin acylases
Site-directed mutants were constructed as described (Alkema
et al., 2002a). The double mutant aF146Y/bF24A was made by
isolating the EcoRV–ClaI fragment of the penicillin acylase
gene containing the aF146Y mutation and subsequent cloning
of this fragment in the plasmid carrying the bF24A mutation.
Purified wild-type and mutant enzymes were obtained as
described (Alkema et al., 2000).
Crystals of wild-type, aF146Y and bF24A PA were grown
at 4C using the hanging-drop vapour diffusion set-up com-
bined with streak seeding. Drops of 6 ml were prepared by
mixing equal volumes of protein [4–10 mg/ml protein in
50 mM 3-(N-morpholino)propanesulfonic acid (MOPS) buf-
fer, pH 7.2] and reservoir solution [50 mM MOPS buffer, pH
7.2, 12–20% (w/v) polyethylene glycol monomethylether
2000 (PEG MME 2k) (Sigma)]. Crystals appeared in 1–2
days and reached typical sizes of 0.2 · 0.15 · 0.1 mm. Crystals
of wild-type and mutant enzymes complexed with PAA and
(R)-a-methylphenylacetic acid (MPAA) were obtained by
co-crystallization in the presence of 2.5 mM PAA and MPAA,
respectively. Prior to data collection, the crystals were trans-
ferred to a solution of 20% (w/v) PEG MME 2k, 50 mM MOPS,
pH 7.2, and 5% (v/v) glycerol. The crystals were flash frozen
using 35% (w/v) PEG MME 2k and 7.5% (v/v) glycerol as
cryoprotectant. For the ligand binding studies, these solutions
contained 2.5 mM PAA or MPAA.
Data collection and refinement
All data were collected using a MacScience DIP2020 image-
plate detector equipped with a CAD4 k-goniostat, with mirror
monochromatized Cu Ka radiation from a Nonius FR591
rotating anode X-ray generator. Data were integrated and
reduced with the programs DENZO and SCALEPACK
(Otwinowski and Minor, 1997). The intensities were converted
to structure factor amplitudes and brought to absolute scale
with TRUNCATE from the CCP4 package (CCP4, 1994). The
structures were refined using CNS (Br€unger et al., 1998) alter-
nated with minor manual model building using O (Jones et al.,
1991) and Quanta (Accelrys). Bulk solvent correction and
overall anisotropic B-factor scaling were applied. Ligands
were identified and modelled in the active site. For PAA in
the bF24A enzyme, the density suggested multiple conforma-
tions, of which the most prominent one was modelled. Final
rounds of refinement were performed with REFMAC
(Murshudov et al., 1999), alternated with ARP/wARP (Lamzin
et al., 1999) to analyse water molecules. The quality of the
structures was validated using PROCHECK (Laskowski et al.,
1993) and programs from the CCP4 suite (CCP4, 1994). The
final models consist of residues a3–a208, b1–b557, one
calcium ion, a variable number of water molecules and ligands
where appropriate. Data collection and refinement statistics
are summarized in Table I.
Determination of binding constants
The binding constants for the inhibitors and substrates were
determined by measuring Kmapp for the hydrolysis of the chro-
mogenic substrate D-2-nitro-5-[(phenylglycyl)amino]benzoic
acid (NIPGB) in the presence of varying substrate and inhibitor
concentrations. Inhibition by PAA and phenylacetamide was
shown to be competitive and it was assumed that inhibition by
the other PAA derivatives was also competitive, because of the
similar binding of these compounds in the PAA binding site
(Svedas et al., 1996). The rate of hydrolysis (V ) of a coloured
Table I. Data processing and refinement statistics: all enzymes crystallized in space group P1
WT-MPAA bF24A bF24A-PAA bF24A-MPAA aF146Y-MPAA
Resolution (s) 30–2.15 30–2.28 19–2.34 30–2.43 30–2.30
Highest resolution shell (s) 2.19–2.14 2.28–2.36 2.38–2.34 2.47–2.43 2.34–2.30
No. of observations 64473 193740 55158 58181 67386
No. of unique reflections 36555 30372 28382 26632 30886
Rsym (%) 6.8 (22.9) 6.8 (16.3) 4.3 (9.8) 3.7 (6.6) 8.2 (17.3)
Completeness (%) 96.7 (87.5) 95.1 (93.6) 92.9 (77.5) 96.2 (95.7) 95.4 (92.7)
< I/s(I)> 10.1 (2.8) 9.6 (3.9) 15.9 (5.5) 21.1 (10.9) 10.2 (4.6)
R-factor (%) 18.4 16.2 16.3 17.3 15.1
Rfree-factor (%) 21.6 21.5 21.8 23.3 20.7
No. of atoms
Protein 6072 6068 6068 6068 6074
Water 319 433 358 360 475
Average B-factor (A˚2)
All atoms 24.07 14.8 17.9 18.1 15.7
Solvent 28.61 16.3 18.0 22.5 17.9
Ligand 19.29 – 68.3 21.7 13.4
r.m.s.d. from ideality
Bond lengths 0.016 0.013 0.020 0.009 0.010
Bond angles 1.589 1.384 1.251 1.131 1.267
Dihedral angles 18.9 15.783 16.076 16.787 17.128
Estimated coordinate error from
sAa 0.21 0.24 0.27 0.21 0.18
PDB accession number 1k7d 1xj9 1k5q 1k5s 1kec
aAs described in Read (1986).
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substrate (S) is given by
V =
Vmax S½ 
Km + S½  ð1Þ
where Km is the Michaelis–Menten constant for S and Vmax the
rate of conversion at saturating substrate concentration. The
rate (Vi) in the presence of a competitive inhibitor I is given by
Vi =
Vmax S½ 




where Ki is the binding constant of the inhibitor to the enzyme.




Km 1 þ I½ Ki
 
+ S½ 
Km + S½  ð3Þ
from which Ki can be calculated as
Ki =
Km I½ 
Km + S½ ð Þ VVi 1
  ð4Þ
Inhibition experiments were carried out with [S]Km so
that the determination of Ki is independent on the precise
knowledge of Km and [S], reducing the experimental error
in the measurements. If I is an inhibitor, Ki is equal to the
binding constant for binding of the inhibitor to the enzyme.
If I is a substrate, Ki is equal to Km of that substrate. For
phenylglycinamide and phenylacetamide, the Km values are
equal to the dissociation constants Ks, since the step leading
to the formation of the covalent intermediate is strongly rate
limiting (Alkema et al., 2003). All experiments were carried
out at 30C, pH 7.0, in 50 mM phosphate buffer.
Chemicals
a-Methylphenylacetic acid, a-ethylphenylacetic acid and
a-hydroxyphenylacetic acid were obtained from Aldrich. The
enantiomers of a-methylphenylacetic acid and a-ethylphenyl-
acetic acid were prepared by classical resolution of their
racemates by crystallization with ()-a-phenylethylamine as
described (Aaron et al., 1967). Enantiomeric purities of the
resulting acids were established with chiral HPLC [Chiralcel
OD, hexane–2-propanol–acetic acid (98:2:1), flow-rate
0.5 ml/min] and found to be >95%. Phenylglycinamide was
obtained from DSM-Gist (Delft, The Netherlands). NIPGB was
obtained from Syncom (Groningen, The Netherlands). Phenyl-
acetamide was obtained as described (Alkema et al., 2003).
Results and discussion
Binding constants for PAA derivatives
The objective of this study was to obtain insight into the factors
that play a role in the binding of Ca-substituted compounds to
penicillin acylase (PA). To this end we determined the binding
constants of various PAA derivatives with distinct substituents
at the Ca position, varying in size, polarity and ability to accept
or donate hydrogen bonds. For these experiments wild-type
and the two active site mutants aF146Y and bF24A were
used, in addition to the double mutant aF146Y/bF24A. In
the wild-type enzyme, aF146 and bF24 line the acyl binding
pocket in the active site (Duggleby et al., 1995; Done et al.,
1998; McVey et al., 2001; Alkema et al., 2002a; Morillas et al.,
2003). They play a role in substrate binding through hydro-
phobic interactions with the phenyl ring of the substrate. Pre-
vious studies have shown that the bF24A and aF146Y mutants
have increased affinities for phenylglycine methyl ester and
phenylglycinamide, which are used for the production of ampi-
cillin (Alkema et al., 2002a).
The wild-type enzyme had a Ki for PAA of 0.06 mM and
showed a decreasing affinity with increasing size and polarity
of the Ca substituent (Table II). A methyl group on the Ca
position led to a 10-fold reduced affinity, whereas an OH group
caused a more than 200-fold reduced affinity. The zwitterionic
phenylglycine did not inhibit the enzyme, indicating that a
Table II. Inhibition constants of wild-type penicillin acylase and the mutants aF146Y, bF24A and aF146Y/bF24A for Ca-substituted phenylacetic acid
derivatives
Ligand R1 R2 WT bF24A aF146Y aF146Y/bF24A
Ki (mM) KiR/KiS Ki (mM) KiR/KiS Ki (mM) KiR/KiS Ki (mM) KiR/KiS
Phenylacetic acid H OH 0.06 – 1.1 – 0.03 – 1 –
(R)-a-Methylphenylacetic acid CH3 OH 0.47 0.42 0.124 0.083 0.2 0.25 0.076 0.211
(S)-a-Methylphenylacetic acid CH3 OH 1.1 1.5 0.5 0.36
(R)-a-Ethylphenylacetic acid CH2CH3 OH 5.7 2.7 0.4 0.36 3.3 3.3 0.276 0.745
(S)-a-Ethylphenylacetic acid CH2CH3 OH 2.1 1.1 1.0 0.37
(R)-a-Hydroxyphenylacetic acid OH OH 31 3.1 3.5 0.61 13 2.9 6.2 0.76
(S)-a-Hydroxyphenylacetic acid OH OH 10 5.7 4.05 8.2
(R)-Phenylglycine NH2 OH ni
a nia ni ni
(R)-Phenylglycinamide NH2 NH2 40 – 25 – 4 15
Phenylacetamide H NH2 0.2 – 2 – 0.05 – 1.5 –
The values reported are the average of five independent measurements carried out with concentrations [I] of the inhibitor ranging from 0.5Ki to 2Ki. The standard
deviation was in all cases <10% of the average.
aNo inhibition was observed at an inhibitor concentration of 100 mM.
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positive charge on the Ca position prevents the ligand from
binding in the apolar active site. Increasing the size of the
Ca-substituent from a methyl to an ethyl group led to a
more than 10-fold reduced affinity. Interestingly, whereas
the enzyme was enantioselective (determined as KiR/KiS) for
the R-enantiomer of a-methylphenylacetic acid, it had an
opposite enantioselectivity for the low affinity inhibitors a-
ethyl- and a-hydroxyphenylacetic acid. Overall, these results
show that substrate specificity and enantioselectivity of the
wild-type enzyme are determined both by the size and by
the polarity of the substituent at the Ca position, in agreement
with results that were obtained by Svedas et al. (1996).
The Ki values of the bF24A mutant for the various com-
pounds differed significantly from those of the wild-type. The
most striking difference was that the bF24A mutant had a
20-fold increased Ki value for PAA, whereas Ki for PAA deri-
vatives with a substituent at the Ca position ranged from values
equal to wild-type values to values up to 10-fold lower com-
pared with the wild-type enzyme. The substrate with a Ca-
amino group, phenylglycinamide, was also bound with higher
affinity to the mutant enzyme, in contrast to the 10-fold
decreased affinity for phenylacetamide, which contains no
substituent at the Ca position. These findings suggest that a
substituent at the Ca position of PAA is necessary for tight
binding of the ligand to the bF24A active site. Furthermore, the
mutant enzyme had, compared with the wild-type, a higher
enantioselectivity for the R-enantiomers of all ligands, indicat-
ing that the side chain of the residue at position b24 strongly
influences the enantioselectivity of PA.
The aF146Y mutant enzyme showed an increased affinity
for all compounds tested. The largest effect was observed with
phenylglycinamide, for which a 10-fold increased affinity was
found. The increased affinity of the aF146Y mutant for PAA
derivatives did not depend on the type of Ca-substituent and
the enantioselectivity for all compounds was similar to that of
the wild-type enzyme.
In the double mutant aF146Y/bF24A, approximate additiv-
ity of the effects of the single mutations was observed. The
affinity for a-methylphenylacetic acid and a-ethylphenylacetic
acid was higher than the affinity of both single mutants. For the
other Ca-substituted ligands, the Ki values averaged those of
the single mutants with the exception of PAA, for which the
aF146Y/bF24A mutant showed the same low affinity as the
single bF24A mutant. As a result, the double mutant had a
44-fold increased preference for phenylglycinamide over PAA
(KiPGA/KiPAA = 0.07), compared with the wild-type (KiPGA/
KiPAA = 0.0015).
Structure of wild-type enzyme co-crystallized with MPAA
The kinetic data for the wild-type enzyme showed that sub-
stituents at the Ca atom of PAA result in a decreased affinity
and that the stereoselectivity of the enzyme is dependent on
the type of substituent at the Ca position. To obtain a structural
explanation for these observations, we determined the crystal
structure of wild-type penicillin acylase in a complex with
(R)-a-methylphenylacetic acid (MPAA). This structure
revealed that MPAA is bound in the acyl binding site of the
enzyme, where it is stabilized by hydrophobic interactions with
the side chains of aM142, bF146, bF24 and bI177, and by
hydrogen bonds with bA69:N and bN241:Nd2 (Figure 1).
The mode of MPAA binding is similar to that reported pre-
viously for PAA (Duggleby et al., 1995), but small shifts of the
active site residues and the ligand are necessary to accommo-
date the methyl substituent at the Ca position. For instance, the
Ca carbon atom of MPAA shifts by 1.1 s towards the phenyl
ring of aF146, and the phenyl rings of aF146 and bF24, on
both sides of the Ca atom, move by 0.5 s. In this way the
methyl group of MPAA comes at van der Waals distance from
bF24:Cd1 (3.6 s) and aF146:Ce2 (3.5 s) and is also close to
bS1:Og (3.2 s) and bQ23:O (3.0 s) (Figure 1).
Since the MPAA Ca–CH3 bond is directed towards
bF24:Ca, with the methyl carbon atom at 4.1 s from bF24:
Ca, accommodation of a larger ethyl group is not possible
without conformational changes of the protein or a different
binding mode of the ligand. Thus, (R)-a-ethylphenylacetic acid
cannot bind in the active site in a similar way to MPAA.
Likewise, the ethyl substituent of (S)-a-ethylphenylacetic
would come too close to aF146 to be accommodated without
conformational changes. The 10-fold lower affinity for a-
ethylphenylacetic acid compared with a-methylphenylacetic
acid and the reversal of enantioselectivity from 2.7 for the
wild-type to 0.36 for the bF24A mutant confirm that an
ethyl substituent is not easily accommodated in the active
site. The structure suggests that residues aF146 and bF24
limit the allowed size of the Ca-substituent. The apolar nature
of these residues, together with the overall hydrophobic char-
acter of the acyl-binding pocket, also explains the enzyme’s
low affinity for substrates with polar substituents (Table II).
Structure of bF24A
The affinity of PA for (R)-methyl- and (R)-ethyl-PAA can be
increased by removing the aromatic ring of residue bF24 (see
Table II). To ascertain the structural basis of this increased
affinity, we determined the crystal structures of bF24A PA and
its complexes with PAA and MPAA (Figure 2). In these struc-
tures, the active-site and oxyanion-hole residues bS1, bA69
and bN241 occupy almost the same position as in the wild-type
enzyme, and also the loop-containing residue bF24 has hardly
undergone positional rearrangements. In contrast, residues
aN144–aF146 and bY31 show considerable differences.
The a-helical conformation of aN144–aF146 is distorted.
As a result, residues aR145 and aF146 have moved away,
creating a more open and accessible active site. Residue
bY31 has moved towards the acyl binding pocket and occupies
some of the space created by the bF24A mutation. The more
open active site of the bF24A mutant is very similar to the open
conformation that was observed in the enzyme–penicillin G
complex and in enzyme complexes with disubstituted phenyl-
acetic acids (Done et al., 1998; Alkema et al., 2000).
Binding of PAA in the active site of bF24A penicillin acy-
lase leaves the open conformation of the empty bF24A enzyme
intact. Interestingly, the positions of both the phenyl ring and
the carboxylate moiety of PAA are different from those in the
wild-type enzyme (Figure 2B). Although the electron density
indicates that PAA is present in more than one conformation,
it is clear that the compound has lost the hydrogen bonds with
the oxyanion-hole atoms bA69:N (at 4.2 s distance) and
bN241:Nd2 (5.2 s) that were observed in the wild-type
enzyme. The hydrophobic interactions with the side chains
of aM142 and aF146 are also not conserved. The loss of
binding interactions is in agreement with the 20-fold reduced
affinity of this mutant for PAA (Table II).
In contrast, the affinity of the bF24A mutant enzyme for
MPAA is higher than that of wild-type PA (Table II). The
W.B.L.Alkema et al.
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crystal structure of this PA mutant with MPAA bound in the
active site reveals that the open conformation of the bF24A and
bF24A–PAA structures is not present in the bF24A–MPAA
complex. Instead, MPAA is bound in a very similar way to that
in the wild-type enzyme (Figure 2C) with aF146 moved in to
cover the acyl binding site. MPAA has moved about 0.6 s
towards bA24:CB, occupying part of the space created by the
bF24A mutation. Although bY31 also takes some of the space
caused by the mutation, sufficient space remains to accommo-
date an ethyl group or an even larger substituent. This suggests
that whereas a-methylphenylacetic acid and a-ethylphenyl-
acetic acid have different binding modes in the wild-type
enzyme, they bind in a similar way in the bF24A mutant.
This is corroborated by the kinetic data, which show that
the two substrates bind with similar affinities and enantioselec-
tivities to the bF24A mutant.
Based on kinetic data, it was concluded that a Ca-substituent
is necessary for tight binding of a ligand in the bF24A active
site. The structural data show that tight binding is correlated
with a switch from the open to the closed conformation. This
leads to restored hydrophobic enzyme–ligand contacts with
residues from the acyl-binding site and restored hydrogen
bonds of the substrate carbonyl oxygen with the oxyanion-
hole residues. A similar correlation between the Ki values
and the presence of an open or closed conformation has
been observed for the binding of para- and meta-substituted
phenylacetic acids to PA (Done et al., 1998), supporting the
functional relevance of the observed conformational changes
for the enzyme’s substrate preferences.
Structure of aF146Y co-crystallized with MPAA
The aF146Y mutant enzyme has an increased affinity for PAA
and the Ca-substituted derivatives tested. The crystal structure
of this mutant with bound MPAA shows that MPAA binds in a
similar way to the enzyme as to the wild-type and the bF24A
mutant. The additional OH group in the aF146Y mutant is
accommodated without conformational changes of the protein
or the ligand. It has van der Waals contacts with aR145:NH2
and the Ca-substituent of the ligand, and makes a water-
mediated hydrogen bond to Q23:O (Figure 3). The Ca–CH3
bond of MPAA and the CZ–OH bond of aY146 are directed
parallel to each other. This precludes hydrogen bond formation
in case of an OH or NH2 substituent at the Ca position, assum-































Fig. 1. Structure of wild-type penicillin acylase complexed with MPAA. (A) Simulated annealed omit map of the density of aR145, aF146, bS1, bF24, bQ23 and
MPAA, contoured at 1s. The most important interactions between the enzyme and the Ca substituent are given with dashed lines. (B) Superposition of the structures of
wild-type complexed with MPAA (black bonds) and PAA (open bonds). PAA and MPAA bind in essentially the same way to the wild-type enzyme, but a small
positional shift of MPAA,aF146 and bF24 is necessary to accommodate the extra methyl group in MPAA in the active site. All figures were prepared using Molscript
(Kraulis, 1991) and Bobscript (Esnouf, 1997).
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increased affinity of the aF146Y mutant for the R-enantiomers
of the PAA derivatives may therefore be due to the added
van der Waals interactions between aY146:OH and the Ca
substituent.
Interaction of the aF146Y/bF24A double mutant with ligands
On the basis of the crystal structures of the single mutants and
the wild-type enzyme, a structural explanation for some of the
properties of the aF146Y/bF24A double mutant can be
deduced. This mutant has the same low affinity for PAA
and phenylacetamide as the bF24A mutant, whereas the affin-
ity for the Ca-substituted ligands a-methylphenylacetic acid
and a-ethylphenylacetic acid is 3- to 10-fold higher than the
wild-type enzyme. This suggests that the same open and closed
forms regulate ligand binding as observed for the bF24A
























































Fig. 2. Stereo view of the active-site structures of wild-type (black bonds) and bF24A (open bonds) penicillin acylase. (A) Superposition of the structures of wild-




closed form, the affinity of the double mutant is higher than the
affinity of each of the single mutants, indicating that the effects
of the single mutations are additive. The combination of the
lower steric hindrance caused by the bF24A mutation and the
improved enzyme–ligand interactions of the aF146Y mutant
thus results in an almost 10-fold increased affinity of the
aF146Y/bF24A double mutant for a-methylphenylacetic
acid compared with the wild-type enzyme (Table II).
Structural comparison of open conformations
The data presented here show that ligand-induced structural
rearrangements of the active site of PA play an important role
in ligand binding. This is evident, for example, from the transi-
tion from an open to a closed active site that the bF24A mutant
undergoes upon binding of a-methylphenylacetic acid. Sim-
ilarly, binding of penicillin G and 3,4-dihydroxyphenylacetic
acid to the wild-type enzyme cause the enzyme to switch from
the closed to the open conformation (Done et al., 1998; Alkema
et al., 2000; Morillas et al., 2003). Superposition of these open
and closed conformations shows that in all cases the conforma-
tional change involves the movement of the same two resi-
dues, aR145 and aF146, whereas the other residues of the acyl
binding site, e.g. aM142, bF24, bV56, and bS67, and the
catalytic bS1 do not change position (Figure 4). In all open
structures the side chain of aR145 occupies the same position,
making a water-mediated hydrogen bond to the main-chain
carbonyl oxygen of bF460. In the structure with penicillin G
and the empty bF24A structure, an additional water-mediated
H-bond to aD68:OD2 further stabilizes the side chain of this
residue. The side chain of aR145 also assists in transition-state
stabilization in the hydrolysis of penicillin G by the formation
of a hydrogen bond between aR145:NH1 and the carboxylate
group of the thiazolidine ring of the 6-APA group (Alkema
et al., 2002b). The fact that the same position is occupied by
aR145, irrespective of whether the open conformation is
caused by a mutation in the enzyme, or by binding a substrate
or inhibitor, indicates that this open conformation corresponds
to a distinct low-energy conformation of the enzyme, in line
with suggestions made by Done et al. (1998).
In contrast to the well-defined open position of the side chain
of aR145, the side chain of aF146 has multiple conformations
(Figure 4), depending on the nature of the bound ligands. In the
enzyme–penicillin G complex the phenyl ring has van der
Waals contacts with the b-lactam moiety of the substrate. In











Fig. 4. Comparison of structures of PA in the open and closed conformation.
The open conformations are induced by binding of the substrate penicillin G
(white), binding of the inhibitor 3,4-dihydroxyphenylacetic acid (dark grey) and
the bF24A mutation (light grey). The closed conformation of the wild-type
enzyme complexed with PAA is shown in black. In all open conformations
aR145 occupies the same position, in which the side chain is stabilized by
hydrogen bonding to bF460:O, mediated by a water molecule (Wat). The
side chain of aF146 can adopt multiple conformations dependent on the type
of ligand that is bound in the active site. The positions of the residues in the
catalytic centre, bS1, bA69 and bN241 and in the acyl binding site bF24, bV56





















Fig. 3. Stereo view of the active site of aF146Y complexed with MPAA. The structure of the mutant, shown in black, is superimposed on the WT-MPAA structure,
shown in open bonds.
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ring shifts to give an optimal configuration for aromatic–
aromatic interactions (Done et al., 1998). The plasticity of
aF146 provides an explanation for the ability of (S)-
a-ethylphenylacetic acid still to bind to the enzyme, even
though the structure of the wild-type enzyme shows that steric
hindrance with aF146 would occur. The conformational
change in PA seems to serve two purposes. One function is
to create additional space in the active site to allow binding of
substrates and inhibitors that do not fit in the pre-aligned active
site. Second, aF146 and aR145 reorient to provide additional
substrate binding interactions.
The kinetic and structural data presented in this paper have
provided insight into the binding of Ca-substituted phenyl-
acetic acids, which are used as acyl donors in the synthesis
of semi-synthetic b-lactam antibiotics. Our results show that
the size of the substituent and hydrophobicity of the active site
and also induced fit mechanisms are the major determinants for
substrate specificity in PA. The double mutant aF146Y/bF24A
showed a 20-fold reduced inhibition by PAA and an almost
3-fold increased specificity for the substrate phenylglycina-
mide, indicating that site-directed mutagenesis is a promising
way to tailor enzymatic activity towards synthetic substrates
that are used in the production of b-lactam antibiotics.
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